The future of complementary and alternative medicine for cancer

Cancer Investigation

Volumn 23, Issue 5, 2005, Pages 420-426

  Kronenberg, Fredi ^a   Mindes, Janet ^a   Jacobson, Judith S ^b,c  

^a Columbia University ^*  (United States)

^b Mailman School of Public Health ^*  (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Alternative medicine; Cancer; Complementary medicine; Integrative medicine

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; AYURVEDIC DRUG; CHINESE DRUG; DIETHYLSTILBESTROL; HERBACEOUS AGENT; INDOMETACIN; MELATONIN; MULTIVITAMIN; PC SPES; PROSTATE SPECIFIC ANTIGEN; SELENIUM; WARFARIN;

ACUPUNCTURE; ALTERNATIVE MEDICINE; ANAPHYLAXIS; BIOLOGICAL THERAPY; CANCER THERAPY; CHINESE MEDICINE; CLINICAL PRACTICE; CLINICAL TRIAL; COPING BEHAVIOR; DIET SUPPLEMENTATION; DIET THERAPY; DRUG CONTAMINATION; ENERGY; HEALING; HERB; HERBAL MEDICINE; HUMAN; HYPNOSIS; LIFESTYLE; LIVER TOXICITY; MAGNET; MANIPULATIVE MEDICINE; MASSAGE; MEDITATION; MUSIC THERAPY; NEPHROTOXICITY; PHYSICIAN; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RELIGION; REVIEW; UNITED STATES; VEGETARIAN DIET; WELLBEING;

COMPLEMENTARY THERAPIES; DRUGS, CHINESE HERBAL; HUMANS; NEOPLASMS; QUALITY OF LIFE;

EID: 24944436212     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-67159     Document Type: Review

References (48)

1. Barnes, P.M.; Powell-Griner, E.; McFann, K.; Nahin, R.L. Complementary and alternative medicine use among adults: United States, 2002. CDC Adv. Data Report #343. 2004, 1-17.
2. Eisenberg, D.M.; Davis, R.B.; Ettner, S.L.; Appel, S.; et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. J. Am. Med. Assoc. 1998, 280, 1569-1575.
3. Kessler, R.C.; Davis, R.B.; Foster, D.F.; Van Rompay, M.I.; et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann. Intern. Med. 2001, 155, 262-268.
4. Cassileth, B.R. Complementary therapies: the American experience. Support. Care Cancer 2000, 8, 16-23.
5. Cassileth, B.R.; Lusk, E.J.; Strouse, T.B.; Bodenheimer, B.J. Contemporary unorthodox treatments in cancer medicine. A study of patients, treatments, and practitioners. Ann. Intern. Med. 1984, 101, 105-112.
6. SEER Cancer Statistics Review, 1973-1998; National Cancer Institute: Bethesda, MD, 2001.
7. Robinson, E.; Adler, Z.; Nasrallah, S.; Kuten, A.; Steiner, M.; et al. Clinical characteristics of patients with a second primary tumor in the endometrium or ovary. Eur. J. Gynaecol. Oncol. 1995, 16, 195-198.
8. Ashbury, F.D.; Findlay, H.; Reynolds, B.; McKerracher, K. A Canadian survey of cancer patients' experiences: are their needs being met? J. Pain Symptom Manag. 1998, 16, 298-306.
9. Patterson, R.E.; Neuhouser, M.L.; Hedderson, M.M.; Schwartz, S.M.; Standish, L.J.; Bowen, D.J.; et al. Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J. Altern. Complement. Med. 2002, 8, 477-485.
10. Jacobson, J.; Troxel, A.; Verret, W.V.; Sealey, D.; Sandoval, R.; et al. In Breast cancer risk, race/ethnicity, and use of complementary and alternative medicine, Presented at the International Scientific Conference on Complementary, Alternative and Integrative Medicine Research, Boston, MA, April 12, 2002.
11. Paltiel, O.; Avitzour, M.; Peretz, T.; Cherny, N.; Kaduri, L.; Pfeffer, R.M.; et al. Determinants of the use of complementary therapies by patients with cancer. J. Clin. Oncol. 2001, 19, 2439-2448.
12. Prasad, K.M.; Cole, W.C.; Kumar, B.; Prasad, K.C. Scientific rationale for using high-dose multiple micronutrients as an adjunct to standard and experimental cancer therapies. [Review] [78 refs.]. J. Am. Coll. Nutr. 2001, 20, 450S-463S.
13. De Lemos, M. Safety issues of soy phytoestrogens in breast cancer patients. J. Clin. Oncol. 2002, 20, 3040-3041.
14. Pinn, G. Adverse effects associated with herbal medicine. [Review] [45 refs.]. Aust. Fam. Physician 2001, 30, 1070-1075.
15. Ashar, B.; Vargo, E. Shark cartilage-induced hepatitis. Ann. Intern. Med. 1996, 125, 780-781.
16. Herxheimer, A.; Petrie, K.J. Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst. Rev. 2002, CD001520.
17. Sloan, R.P.; Bagiella, E.; VandeCreek, L.; Hover, M.; Casalone, C.; Jinpu, H.; et al. Should physicians prescribe religious activities? N. Engl. J. Med. 2000, 342, 1913-1916.
18. Gupta, S.K.; Kaleekal, T.; Joshi, S. Misuse of corticosteroids in some of the drugs dispensed as preparations from alternative systems of medicine in India. Pharmacoepidemiol. Drug Saf. 2000, 9, 599-602.
19. Omura, Y. Impression on observing psychic surgery and healing in Brazil that appear to incorporate (+) qi gong energy and the use of acupuncture points. Acupunct. Electro-Ther. Res. 1997, 22, 17-33.
20. Gecsedi, R.A. Massage therapy for patients with cancer. Clin. J. Oncol. Nurs. 2002, 6, 52-54.
21. Mansour, A.A.; Beuche, M.; Laing, G.; Leis, A.; Nurse, J. A study to test the effectiveness of placebo Reiki standardization procedures developed for a planned Reiki efficacy study. J. Altern. Complement. Med. 1999, 5, 153-164.
22. Ernst, E. Colonic irrigation and the theory of autointoxication: a triumph of ignorance over science. J. Clin. Gastroenterol. 1997, 24, 196-198.
23. Richardson, M.A.; Russell, N.C.; Sanders, T.; Barrett, R.; Salveson, C. Assessment of outcomes at alternative medicine cancer clinics: a feasibility study. J. Altern. Complement. Med. 2001, 7, 19-32.
24. Weitzman, S. Alternative nutritional cancer therapies. Int. J. Cancer, Suppl. 1998, 11, 69-72.
25. Weiger, W.A.; Smith, M.R.; Boon, H.; Richardson, M.A.; Kapchuk, T.; Eisenberg, D.M. Advising patients who seek complementary and alternative medical therapies for cancer. Ann. Intern. Med. 2002, 137, 889-903.
26. Vickers, A.J.; Cassileth, B.R. Unconventional therapies for cancer and cancer-related symptoms. Lancet Oncol. 2001, 2, 226-232.
27. Begbie, S.D.; Kerestes, Z.L.; Bell, D.R. Patterns of alternative medicine use by cancer patients. Med. J. Aust. 1996, 165, 545-548.
28. Eisenberg, D.M.; Kessler, R.C.; Van Rompay, M.I.; Kaptchuk, T.J.; Wilkey, S.A.; Appel, S.; et al. Perceptions about complementary therapies relative to conventional therapies among adults who use both: results from a national survey. Ann. Intern. Med. 2001, 135, 344-351.
29. Herbert, V. Underreporting of dietary supplements to health-care providers does great harm. Mayo Clin. Proc. 1999, 74, 531-532.
30. Hutt, N.; Kopferschmitt-Kubler, M.; Cabalion, J.; Purohit, A.; Alt, M.; Pauli, G. Anaphylactic reactions after therapeutic injection of mistletoe (Viscum album L.). Allergol. Immunothol. 2001, 29, 201-203.
31. Labriola, D.; Livingston, R. Possible interactions between dietary antioxidants and chemotherapy. Oncology 1999, 13, 1003-1008.
32. Roller, A.; Weller, M. Antioxidants specifically inhibit cisplatin cytotoxicity of human malignant glioma cells. Anticancer Res. 1998, 15, 4493-4497.
33. Biron, P.; Sebban, C.; Gourmet, R.; Chvetzoff, G.; Philip, I.; Blay, J.Y. Research controversies in management of oral mucositis. Support. Care Cancer 2000, 8, 68-71.
34. Hensley, M.L.; Schuchter, L.M.; Lindley, C.; Meropol, N.J.; Cohen, G.I.; Broder, G.; et al. American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J. Clin. Oncol. 2000, 17, 3333-3355.
35. Culy, C.R.; Spencer, C.M. Amifostine: an update on its clinical status as a cytoprotectant in patients with cancer receiving chemotherapy or radiotherapy and its potential therapeutic application in myelodysplastic syndrome. Drugs 2001, 61, 641-684.
36. Sparber, A.; Bauer, L.; Curt, G.; Eisenberg, D.; Levin, T.; Parks, S.; et al. Use of complementary medicine by adult patients participating in cancer clinical trials. Oncol. Nurs. Forum 2000, 27, 623-630.
37. Winawer, S. Healing Lessons; Little Brown: Boston, 1998.
38. Vickers, A.J. Can acupuncture have specific effects on health? A systematic review of acupuncture antiemesis trials. J. R. Soc. Med. 1996, 89, 303-311.
39. Amato, P.; Christophe, S.; Mellon, P.L. Estrogenic activity of herbs commonly used as remedies for menopausal symptoms. Menopause 2002, 9, 145-150.
40. Muscat, M. The Osher Center for Integrative Medicine at UCSF: healing the whole person with 'relationship-centered' medicine. Altern. Ther. Health Med. 1999, 5, 36-37.
41. Santa, A. The adoption of complementary and alternative medicine by hospitals: a framework for decision-making. J. Healthc. Manag. 2001, 46, 250-260.
42. Howells, N.; Maher, E.J. Complementary therapists and cancer patient care: developing a regional network to promote co-operation, collaboration, education and patient choice. Eur. J. Cancer Care 1998, 7, 129-134.
43. Cohen, M.H.; Eisenberg, D.M. Potential physician malpractice liability associated with complementary and integrative medical therapies. Ann. Intern. Med. 2002, 136, 596-603.
44. Pan, C.X.; Morrison, R.S.; Ness, J.; Fugh-Berman, A.; Leipzig, R.M. Complementary and alternative medicine in the management of pain, dyspnea, and nausea and vomiting near the end of life. A systematic review. J. Pain Symptom Manag. 2000, 20, 374-387.
45. Berman, B.M.; Hartnoll, S.; Bauseil, B. CAM evaluation comes into the mainstream: NIH Specialized Centers of Research and the University of Maryland Center for Alternative Medicine Research in Arthritis. Complement. Ther. Med. 2000, 8, 119-122.
46. Oh, W.K.; Small, EJ. Complementary and alternative therapies in prostate cancer. Semin. Oncol. 2002, 29, 575-584.
47. Bigler, D.; Guiding, K.M.; Dann, R.; Sheabar, F.Z.; Conaway, M.R.; Theodorescu, D. Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action. Oncogene 2003, 22, 1261-1272.
48. Wadsworth, T.; Poonyagariyagorn, H.K.; Sullivan, E.; Koop, D.R.; Roselli, C. In vivo effect of PC-SPES on prostate growth and hepatic CYP3A expression in rats. J. Pharmacol. Exp. Ther. 2003, 306 (1), 187-194.